Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo-Reference-Cited by-同舟云学术

Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo

Published:2019-03 Issue: Volume:197 Page:182-193
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Ma Yuan,Zhao Wenting,Li Yiding,Pan Yufei,Wang Shuhe,Zhu Yuejie,Kong Lingxuan,Guan Zhu,Wang Jiancheng,Zhang Lihe,Yang Zhenjun

Funder

Ministry of Science and Technology of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference55 articles.

1. Pharmacology of antisense drugs;Bennett;Annu. Rev. Pharmacol. Toxicol.,2017

2. Delivering a disease-modifying treatment for Huntington's disease;Godinho;Drug Discov. Today,2015

3. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy;Chen;Med. Res. Rev.,2018

4. Inotersen treatment for patients with hereditary transthyretin amyloidosis;Benson;N. Engl. J. Med.,2018

5. Disposition and pharmacokinetics of a GalNAc3-conjugated antisense oligonucleotide targeting human lipoprotein (a) in monkeys;Yu;Nucleic Acid Therapeut.,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy;Cancer Letters;2024-08

2. Peptide nanocarriers co-delivering an antisense oligonucleotide and photosensitizer elicit synergistic cytotoxicity;Journal of Colloid and Interface Science;2024-06

3. Bis-2′-F-cGSASMP isomers encapsulated in cytidinyl/cationic lipids act as potent in situ autologous tumor vaccines;Molecular Therapy;2024-06

4. Design and synthesis of nucleotidyl lipids and their application in the targeted delivery of siG12D for pancreatic cancer therapy;Biomedicine & Pharmacotherapy;2024-03

5. Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer;RSC Medicinal Chemistry;2024